Supplier News

Dec 11, 2018
By Pharmaceutical Technology Editors
TrendMiner 2018.R2 software for analysis of time-series data includes the ContextHub platform for expanded, self-service analytics capabilities.
Dec 10, 2018
By Pharmaceutical Technology Editors
FDA has approved Truxima (rituximab-abbs), a biosimilar to Roche’s anti-cancer biologic, Rituxan (rituximab).
Dec 10, 2018
By Pharmaceutical Technology Editors
The company will use GE Healthcare’s off-the-shelf KUBio biologics factory, which is expected to start operations in 2020, to provide development and manufacturing for early- to late-clinical and early-commercial manufacturing stages.
Dec 10, 2018
By Pharmaceutical Technology Editors
The company is investing approximately $14 million to expand biologics packaging capabilities and capacity at its biologics manufacturing facility in Bloomington, IN.
Dec 10, 2018
By Pharmaceutical Technology Editors
The Gold Cone X-Flo Filter Cartridge from Camfil APC stays cleaner and lasts longer than conventional pleated filters.
Dec 10, 2018
By Pharmaceutical Technology Editors
The SafeGuard Preventative Maintenance Solution from PSG’s Griswold provides remote monitoring for a centrifugal pump and its motor.
Dec 05, 2018
By Pharmaceutical Technology Editors
Shire has announced that the European Commission has granted marketing authorisation for Takhzyro (lanadelumab) subcutaneous injection.
Dec 05, 2018
By Pharmaceutical Technology Editors
Novartis has announced that the European Commission has approved Gilenya (fingolimod) as a treatment for children and adolescents (10–17 years) with relapsing-remitting forms of multiple sclerosis (RRMS).
Dec 05, 2018
By Pharmaceutical Technology Editors
GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.
Nov 30, 2018
By Pharmaceutical Technology Editors
The investment builds on a collaboration the companies entered into in 2007 for various biomanufacturing projects.
native1_300x100
lorem ipsum